Food and Drug Administration's drug shortage list. The change in status comes nearly six months after Novo Nordisk, the maker of the popular drugs used for weight loss, announced it would invest over $6 billion dollars to help meet the increased demand for the drugs amid both shortages and ...
Though compounded semaglutide, for example, contains the same active ingredient as Wegovy, the Food and Drug Administration doesn’t verify the safety, quality, or effectiveness of such mixed or altered meds. Given the surging popularity of obesity management drugs in recent years, the FDA put ...
Antibiotic Injectable Coming Off FDA Shortage ListDa Hee HanPharmD
October 24th 2024 FDA To Reevaluate Removal of Tirzepatide From Drug Shortage List Ashley Gallagher, Associate Editor October 22nd 2024 Study: Pharmacokinetics, Safety Comparable Between CT-P13 Autoinjector and Pre-Filled Syringe Ashley Gallagher, Associate EditorRecent...
STAT’s Matt Herper wrote about what he sees as thebiggest medical advances of 2024. “My expertise? I’m a reporter who has been watching medical innovation for two decades,” he noted. Can you guess what he included on the list? Hints: One class of drugs going beyond obesity, one tr...
After years ofongoing shortagesdue to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration'sdrug shortage list. The change in status comes nearly six months after Novo Nordisk, the maker of the popular drugs...
BOSTON--(BUSINESS WIRE)--Dec. 20, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane ...
SILVER SPRING, Md.,Dec. 6, 2024/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA published the draft guidance, "Expedited Program for Serious Conditions — Accelerated Approval of Drugs an...
The U.S. Food and Drug Administration is weighing whether to remove Wegovy from its shortage list, which has allowedcompounding pharmacies to combine and mix copiesof the highly sought-after drugs for more than a year. Americans who cannot afford Wegovy or have struggled to find it hav...
May 2024 CT40 November 2023 May 2024 This regulatory discretion by the FDA does not extend beyond the lots listed above which have now been listed on the FDA Drug Shortage webpage: https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-d...